Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer

ConclusionsEfficacy of first-line FP was not different by MMR status in mGC patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research